Literature DB >> 24738802

Concluding results from the first phase of the Zurich Unexpected Difficult Airway course based on exercise of technical skills.

P Biro1, B Grande, S L Kind, D R Spahn, O M Theusinger.   

Abstract

We analysed the results of the first phase of the Zurich Unexpected Difficult Airway course. Two hundred and twenty-eight staff members performed a total of 2712 standardised airway rescue procedures with four airway devices: SensaScope™, LMA Fastrach™, Laryngeal Tube and needle cricothyrodotomy. Four consecutive attempts were performed using each device. We analysed the success rate and the time needed for successful completion for each attempt and device. The success rates and mean (SD) completion times for all participants were 96.2% and 30.2 (15.3) s for the SensaScope, 88.1% and 40.4 (17.2) s for the LMA Fastrach, 99.0% and 12.1 (10.6) s for the Laryngeal Tube and 99.0% and 12.3 (6.1) s for needle cricothyroidotomy. The learning curves resulting from the four consecutive attempts with each device showed a clear pattern of improvement. This institutional airway training course represents a promising method to improve the capability of practitioners to cope with unexpected difficult airway situations.
© 2014 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2014        PMID: 24738802     DOI: 10.1111/anae.12606

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Emergency percutaneous transtracheal jet ventilation in a hypoxic cardiopulmonary resuscitation setting: a life-saving rescue technique.

Authors:  Phi-Vu Dong; Leontien Ter Horst; Ralf Krage
Journal:  BMJ Case Rep       Date:  2018-01-26

2.  SafAIRway: an airway training for pulmonologists performing a flexible bronchoscopy with nonanesthesiologist administered propofol sedation: A prospective evaluation.

Authors:  Melanie Schulze; Bastian Grande; Michaela Kolbe; Sarah Kriech; Christoph B Nöthiger; Malcolm Kohler; Donat R Spahn; Daniel Franzen
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.